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Themicroenvironment provides cues that control the
behavior of epithelial stem and progenitor cells.
Here, we identify matrix metalloproteinase-3
(MMP3) as a regulator of Wnt signaling and mam-
mary stem cell (MaSC) activity. We show that
MMP3 overexpression promotes hyperplastic
epithelial growth, surprisingly, in a nonproteolytic
manner via its hemopexin (HPX) domain. We demon-
strate that MMP3-HPX specifically binds and inacti-
vates Wnt5b, a noncanonical Wnt ligand that inhibits
canonical Wnt signaling and mammary epithelial
outgrowth in vivo. Indeed, transplants overexp-
ressing MMP3 display increased canonical Wnt
signaling, demonstrating that MMP3 is an extracel-
lular regulator of the Wnt signaling pathway.
MMP3-deficient mice exhibit decreased MaSC pop-
ulations and diminished mammary-reconstituting
activity, whereas MMP3 overexpression elevates
MaSC function, indicating that MMP3 is necessary
for the maintenance of MaSCs. Our study reveals a
mechanism by a microenvironmental protease that
regulates Wnt signaling and impacts adult epithelial
stem cell function.
INTRODUCTION
The mammary gland is composed of a highly dynamic epithelial
structure that undergoes constant rounds of remodeling during
puberty, pregnancy, lactation, and involution (Visvader, 2009).
At puberty, the mammary gland forms a branching ductal
network, which connects the nipple to the milk-producing lobu-
loalveolar structures that arise during pregnancy (Sternlicht,
2006). Development and growth of the mammary gland depend
on the function of adult mammary stem cells (MaSCs) (Visvader,
2009). These MaSCs are capable of reconstituting a complete300 Cell Stem Cell 13, 300–313, September 5, 2013 ª2013 Elsevier Imammary epithelial ductal structure when implanted as a single
cell into a cleared fat pad in vivo (Plaks et al., 2013; Shackleton
et al., 2006; Stingl et al., 2006). The morphogenetic changes of
the breast epithelium are closely coordinated within the context
of its microenvironment, which consists of a variety of stromal
cells such as adipocytes, macrophages, and fibroblasts (Lu
and Werb, 2008; Wiseman and Werb, 2002). MaSCs respond
to extracellular signals, such as Wnt ligands, provided by the
stromal cells of the microenvironment. For example, hyperacti-
vation of the canonical Wnt/b-catenin signaling pathway in the
mammary gland expands the MaSC population by 6-fold
(Shackleton et al., 2006), and Wnt ligands are necessary for
self-renewal properties of MaSCs (Zeng and Nusse, 2010).
Constitutive overexpression of the canonical Wnt1 ligand in
this organ ultimately gives rise to tumors, suggesting a direct
link between MaSC accumulation and tumor susceptibility (Li
et al., 2003; Liu et al., 2004).
Matrix metalloproteinases (MMPs) are a family of extracellular
zinc-dependent endopeptidases that contribute to a wide range
of both physiological and pathological processes (Page-McCaw
et al., 2007). Their role in cancer has been ascribed to extracel-
lular matrix degradation and thereby promoting tumor cell inva-
sion and metastasis. However, recent evidence suggests that
the function of MMPs in cancer is more complex because these
enzymes can regulate multiple signaling pathways andmay even
work in a nonproteolytic manner (Kessenbrock et al., 2010).
Whether their role in cancer may involve the regulation of epithe-
lial stem cell function remains unknown.
MMP3/stromelysin-1 is mainly produced by stromal fibro-
blasts and promotes epithelial-branching morphogenesis during
puberty (Kouros-Mehr and Werb, 2006; Wiseman et al., 2003;
Witty et al., 1995). It is frequently upregulated in breast cancer,
where it may also be expressed by malignant epithelial cells
(Egeblad andWerb, 2002). Targeted overexpression of autoacti-
vated MMP3 in mouse mammary glands induces hyperplasias
and breast cancer, demonstrating that it can influence tumor
initiation and alter neoplastic risk (Sternlicht et al., 1999). How-
ever, the cellular and molecular mechanism by which MMP3
affects epithelial homeostasis during normal mammary develop-
ment or breast cancer is still elusive.nc.
Figure 1. MMP3 Induces Hypermorphic Mammary Epithelial Growth
(A) Schematic representation of MMP3-FL. Pre, signal sequence; Pro, inhibitory peptide that was made cleavable by furin; CD, catalytic domain; HPX, HPX-like
domain.
(B) Experimental scheme. Single MECs were isolated from donor mice and transduced with either control or transgene-expressing viruses. Transduced MECs
were transplanted into epithelium-cleared contralateral inguinal mammary fat pads of recipient mice. Reconstitutedmammary glands were analyzed 8–10 weeks
later by fluorescence microscopy.
(C and D) Representative images showing green fluorescence of whole-mount transplants from control (C, i and ii) and MMP3-FL (D, i and ii)-transduced MECs.
MMP3-FL overexpression (n = 10) leads to hypermorphic mammary epithelial branching with significantly increased epithelial outgrowth (asterisks) in nine of ten
(legend continued on next page)
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MMP3 Regulates MaSCs through Wnt SignalingHere, we hypothesized that MMP3 is part of a signaling
network that controls adult stem cell function in the mammary
gland, based on previous studies showing that it affects mam-
mary development and breast tumor formation. Our study id-
entifies MMP3 as an extracellular regulator of MaSCs through
modulation of the Wnt signaling pathway.
RESULTS
MMP3 Overexpression Induces Hyperplastic Epithelial
Growth in Mammary Transplants
Overexpression of MMP3 in transgenic mouse models induces
mammary epithelial hyperplasia (Sternlicht et al., 1999;Wiseman
et al., 2003). To investigate the molecular mechanism underlying
MMP3-mediated pathology, we asked whether lentivirus-medi-
ated overexpression of MMP3 in MaSCs could recapitulate this
hyperplastic phenotype using the mammary fat pad transplanta-
tionmodel (Welm et al., 2008). We chose this approach because,
compared to transgenic models, it facilitates rapid structure/
function analysis of the various MMP3 domains.
To this end, we generated lentiviral constructs to express
furin-activatable full-lengthmouseMMP3 (MMP3-FL) (Figure 1A)
and confirmed that MMP3 was processed by the ubiquitously
expressed convertase furin because it was secreted as an active
proteinase (Figure S1A available online) and overexpressed by
about 2.5-fold in primary mammary epithelial cells (MECs)
(Figure S1B). These lentiviral constructs also contain an internal
ribosome entry site (IRES) allowing expression of a fluorescent
reporter gene, which enabled us to visualize the transduced
epithelium in transplant whole mounts by fluorescence micro-
scopy (outlined in Figure 1B).
MECs from 8- to 16-week-old donor mice were transduced
with MMP3-FL or control virus and transplanted into epithe-
lium-cleared fat pads of pubescent recipients. Transplants
were harvested 8–10 weeks after transplantation. Control out-
growths displayed normal epithelial morphology and regular
branching (Figures 1C, 1E, and S1C), whereas transplants
overexpressing MMP3-FL exhibited hypermorphic epithelial
outgrowth and precocious lobuloalveolar development with
excessive branching (Figures 1D, 1F, and S1D). We also
observed enhanced accumulation of collagen around the ducts
of MMP3-overexpressing transplants (Figure 1Fiii), as observed
previously in MMP3 transgenic mice (Sternlicht et al., 2000).
Therefore, MMP3 overexpression induces hyperplastic epithelial
growth in mammary transplants, confirming that this approach is
valid for further interrogation of MMP3 function.
MMP3 Induces Hypermorphic Outgrowth via the
Hemopexin Domain, Independent of Its Proteolytic
Activity
MMP3 contains two major functional domains: a catalytic
domain that mediates proteolytic cleavage of substrate mole-transplants, whereas control transplants (n = 10) showed regular epithelial grow
outgrowth phenotype is shown. Scale bars represent 1 mm.
(E and F) H&E (i and ii) and Masson’s trichrome (iii)-stained sections of mammary
expressing MMP3-FL displayed strongly increased epithelial branching (i and ii)
vealed by blue staining in Masson’s trichrome (iii). Scale bars represent 20 mm.
See also Figure S1.
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direct MMP3 specificity (Piccard et al., 2007). To determine
whether proteolytic activity is required forMMP3-induced hyper-
morphic outgrowth, we generated a lentiviral clone expressing
a proteolytically inactive ‘‘E to A’’ mutant of MMP3 (MMP3-FL-
E/A) (Crabbe et al., 1994) and compared this to proteolytically
active MMP3-FL using our transplant approach. Surprisingly,
overexpression of both MMP3-FL (Figure 2A) and nonproteolytic
MMP3-FL-E/A (Figures 2B and S2A) showed a comparable
phenotype with increased epithelial outgrowth and hypermor-
phic branching. We then generated lentiviral constructs that
express and secrete only the HPX domain ofMMP3 (Figure S2B).
Of importance, expression of the MMP3-HPX domain was suffi-
cient to induce hypermorphic epithelial outgrowth compared to
control samples (Figures 2C, 2D, and S2C), which was strikingly
similar to MMP3-FL overexpression in contralateral transplants
in the same mouse (Figures 2E and 2F).
MMP10/stromelysin-2 is the closest relative of MMP3, with an
HPX domain that is about 67% identical to MMP3-HPX (Sirum
and Brinckerhoff, 1989). Overexpression of MMP10-HPX in
MEC transplants was ineffective at increasing epithelial
outgrowth (Figure 2G) when compared to MMP3-HPX (Fig-
ure 2H). These results indicate that MMP3 catalytic activity is
not required and that the HPX domain is sufficient to induce hy-
perplastic mammary growth.
MMP3-HPX Specifically Interacts with Wnt5b
To shed light on the molecular mechanism by which MMP3 pro-
motes hypermorphic epithelial outgrowth, we used MMP3-HPX
as bait in a yeast two-hybrid (Y2H) screen (Bartel and Fields,
1995; McQuibban et al., 2000) with a mouse mammary gland
cDNA library (Figure 3A). We identified 98 candidates that dis-
played plasmid-dependent activation of both Y2H reporters. Of
these, 58 clones were fused in frame to the GAL4 activation
domain, representing a total of 21 different genes, mostly encod-
ing intracellular proteins (Table S1). However, we identified two
extracellular interacting proteins (Figure 3B). One of these clones
contained the C-terminal 280 amino acids of ADAMTS-18 and
was not further pursued in this study. The second clone con-
tained the C-terminal 147 amino acids of Wnt5b. This candidate
was promising because deregulated Wnt signaling occurs in a
wide variety of cancers and has been implicated in the control
of MaSC function (Reya and Clevers, 2005).
We then analyzed the specificity of this interaction and found
that the HPX domain of MMP3 interacted with the C termini of
both Wnt5a and Wnt5b in Y2H assays (Figure 3C), but not with
the C termini of other Wnt ligands expressed in the mammary
gland (Wnt2, 4, 6, 7b, or 10b; Kouros-Mehr and Werb, 2006).
Moreover, the HPX domains of MMP2, MMP10, and MMP14,
which are also expressed in the mammary gland, did not interact
with any of these Wnts. The high degree of specificity of this
interaction suggests that the ability to bind Wnt5b may be keyth and branching in all cases. Schematic depiction of the respective epithelial
transplants from control (E) and MMP3-FL (F)-transduced MECs. Transplants
and prominent deposition of collagen around ductal structures (arrow), as re-
nc.
(legend on next page)
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growth.
To identify the Wnt5b domains responsible for this interaction,
we performed a deletional analysis of the Wnt5b Y2H clone,
which revealed a minimal MMP3 binding domain of 55 amino
acids (Figure 3D). We then explored the molecular determinants
on MMP3-HPX necessary for the binding of Wnt5b. The HPX
domain of MMP3 consists of a four-bladed propeller-like domain
that is connected to the catalytic domain via a linker region (Pic-
card et al., 2007). We used a hinge/blade-swapping approach
and replaced each subdomain of MMP3-HPX with the corre-
sponding one of the MMP10-HPX and assayed for binding to
Wnt5b by Y2H. We found that the hinge region and most blades
of MMP3-HPX are required for binding Wnt5b (Figure 3E).
We next tested if Wnt5b is a cleavage substrate of MMP3. To
this end, we produced recombinant mouse Wnt5b flanked by
N-terminal Myc and C-terminal HA tags and incubated this
construct with catalytically active mouse MMP3. Indeed, the
MMP3 catalytic domain (Figure 3F) and recombinant MMP3-FL
(data not shown) cleaved soluble Wnt5b at two sites calculated
to be located within the minimal MMP3 binding domain based
on the size of the cleavage fragments. We then generated a
structural model of Wnt5b and the complex of MMP3 with
Wnt5b using comparative protein structure modeling based on
the recently published crystal structure for Wnt8 ligand (Janda
et al., 2012). Our model revealed that the minimal MMP3 binding
domain strongly overlaps with the putative coreceptor domain of
Wnt5b (Figures 3G and 3H), suggesting that MMP3 may antag-
onize Wnt5b function by either interfering with receptor binding
or by proteolytic inactivation.
Wnt5b Acts as a Noncanonical Wnt Ligand that Inhibits
MaSC Function
Although Wnt5b is classified as a noncanonical Wnt ligand, its
downstream signaling pathways are not well characterized. Ca-
nonical Wnts such as Wnt1 or Wnt3a signal through b-catenin,
whereas noncanonical Wnt ligands such as Wnt5a activate the
planar cell polarity (PCP) pathway or induce a Ca2+ response
that leads to the nuclear factor of activated T cell (NFAT) tran-
scriptional activity (Ling et al., 2009). To identify signaling path-
ways downstream of Wnt5b, we incubated nontumorigenic
mouse MEC lines or primary MECs with recombinant mouse
Wnt5b. We did not detect phosphorylation of c-Jun N-terminal
kinase (JNK), which is a hallmark of the noncanonical PCP
pathway (data not shown). However, addition of Wnt5b led to
robust accumulation of NFAT protein in Eph4 cell lysates (Fig-
ure 4A) and in primary MECs (Figure S3A). We also observed a
significant elevation of NFAT transcriptional activity (Figure 4B),Figure 2. MMP3 Promotes Hypermorphic Epithelial Outgrowth via Its H
(A and B) Overexpression of catalytically inactive MMP3 induces hypermorphic
mounts of transplants from either MMP3-FL (A) or catalytically inactive MMP3-FL-
branches. Scale bars represent 1 mm.
(C and D) Whole-mount fluorescence imaging (i and ii) and H&E sections (iii) of tran
MMP3-FL and MMP3-FL-E/A, MMP3-HPX strongly promotes mammary epitheli
(E–H) Comparison of MMP3-HPX overexpression to MMP3-FL and MMP10-HP
MECs both promote hypermorphic branching and growth to a similar extent. M
whereas MMP3-HPX-expressing MECs demonstrate hypermorphic outgrowth in
phenotype is shown. Scale bars represent 1 mm.
See also Figure S2.
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MECs. Addition of recombinant MMP3-FL to Eph4 cells did not
affect basal levels of NFAT signaling but significantly reduced
NFAT signaling induced byWnt5b, demonstrating that MMP3 in-
activates Wnt5b.
Noncanonical Wnt ligands may interfere with canonical Wnt
signaling, for example by competing for Frizzled coreceptors
(Grumolato et al., 2010). Indeed, we found that Wnt5b, like the
known canonical Wnt antagonist Dickkopf-related protein
(DKK)-1, significantly reduced Wnt3a-induced b-catenin tran-
scriptional activity in Eph4 cells (Figure 4C). Therefore, Wnt5b
can act as an inhibitor of canonical Wnt signaling.
One of the earliest events in the canonical Wnt signaling
cascade after docking of extracellular Wnt ligand to low-density
lipoprotein receptor-related protein 6 (LRP6) and Frizzled is
phosphorylation of LRP6 (Zeng et al., 2005). Incubation of
NMuMG cells with Wnt3a led to robust phosphorylation of
LRP6, which could be suppressed when coincubated with
Wnt5b or DKK1. MMP3-HPX partially overcame the inhibition
of LRP6 phosphorylation by Wnt5b but did not affect the DKK1
antagonism (Figure 4D).
To address the role of Wnt5b in the regulation of mammary
stem and progenitor cell function, we performed the mammo-
sphere formation assay using single MECs that were incubated
with or without exogenous Wnt5b. We found that Wnt5b inter-
fered with the clonal proliferative capacity of MECs, which was
reversible by addition of MMP3 (Figure 4E). We then used our
transplant assay to determine the impact of Wnt5b overexp-
ression on mammary epithelial outgrowth in vivo (Figure S3B).
Although control mammary transplants showed normal
morphology (Figure 4F), overexpression of Wnt5b or the Wnt
antagonist DKK1 in transplants resulted in strongly decreased
branching morphogenesis and impaired epithelial outgrowth
(Figures 4G, 4H, S3C, and S3D). These results confirm that inhi-
bition of canonical Wnt signaling halts mammary development
and suggest that Wnt5b is a negative regulator of stem cell func-
tion in the mammary gland. Taken together, these studies reveal
that Wnt5b activates the noncanonical Ca2+/NFAT pathway, in-
hibits stem and progenitor capacity in MECs, and is inactivated
by MMP3 (Figure 4I).
MMP3 Overexpression Mimics Activation of Canonical
Wnt Signaling in Mammary Transplants
We next asked whether the MMP3-induced phenotype mimics
overexpression of canonical Wnt ligands. We used lentiviral
transduction of primary MECs to express selected canonical
Wnt ligands (Wnt1, Wnt2, Wnt4; Figure S4A) and determined
their effects on mammary epithelial growth in vivo. Both Wnt1PX Domain
branching. Fluorescent imaging (i) and carmine red-stained (ii and iii) whole
E/A (B; n = 6)-transduced MECs both develop epithelial structures with excess
splants from either control (C) or MMP3-HPX (D; n = 6)-transducedMECs. Like
al branching. Scale bars represent 1 mm (i and ii) and 100 mm (iii).
X in contralateral transplants. MMP3-FL (E) and MMP3-HPX (F)-transduced
ECs expressing MMP10-HPX (G, red) show regular branching and growth,
the contralateral mammary fat pad. Schematic depiction of epithelial growth
nc.
(legend on next page)
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outgrowth comparable to overexpression of MMP3 (Figures
5A–5C). Wnt4 overexpression led to dysplasia of terminal end
buds in the developing mammary transplants (Figure 5D).
MMP3 Overexpression Elevates Canonical Wnt
Signaling
Based upon the above observations, we hypothesized that inac-
tivation of Wnt5b by MMP3 may increase canonical Wnt
signaling in the mammary gland. The latter involves stabilization
and translocation of b-catenin into the nucleus, where it acts as a
transcription factor forWnt-regulated genes such asCyclin D1 or
Axin2 (Clevers and Nusse, 2012). We therefore analyzed tissue
sections from MEC transplants for nuclear localization of b-cat-
enin and observed predominant peripheral membrane staining in
control outgrowths (Figure 5E). Sections from both MMP3-FL-
and Wnt1-overexpressing transplants displayed a marked in-
crease in nuclear b-catenin (Figures 5F and 5G), which was
also observed inMMP3-HPX transplants (Figures S4B and S4C).
Axin2-LacZ transgenic mice express b-galactosidase under
the control of the Wnt-responsive Axin2 gene. This model has
been used as an in vivo reporter for canonical Wnt signaling
and to identify MaSCs (Lustig et al., 2002; van Amerongen
et al., 2012; Zeng and Nusse, 2010). We crossed the Axin2-
LacZ transgene into MMTV-Wnt1 mice and were able to validate
this Wnt reporter in the mammary gland (Figures S4D and S4E).
We then used our transplant assay to overexpress MMP3-FL in
Axin2-LacZ MECs and found that these outgrowths displayed
more robust b-galactosidase staining than control transplants
(Figures 5H and 5I), consistent with MMP3 enhancing canonical
Wnt signaling in the mammary gland and promoting MaSC
populations.
MMP3 Overexpression Promotes MaSC Function
We next used flow cytometry to assess luminal (CD24/CD49flo)
and basal/MaSC-containing CD24/CD49fhi cell populations
(Shackleton et al., 2006; Stingl et al., 2006) in transplants that
overexpress MMP3. We found a significant increase in the
CD24/CD49fhi MaSC-enriched population in mammary glands
overexpressing MMP3 (Figure 6A). This result is in agreement
with increased expression of the MaSC marker Axin2-LacZ inFigure 3. MMP3 Specifically Binds and Cleaves Wnt5b
(A) Structural domains of MMP3-FL. The HPX domain with hinge region was use
(B) Summary of the Y2H screen. MMP3-HPX specifically interacts with the C-te
growth in the absence of adenine and were verified by b-galactosidase activity,
(C) Y2H interactions betweenMMPs andWnts expressed in themammary gland: o
terminus of Wnt5b is indicated in parentheses.
(D) A deletional approach identified a minimal MMP3 binding domain of 55 amino
MMP3-HPX.
(E) A blade-swapping approach revealed that the entire HPX domain of MMP3 is n
HPX to create unique restriction sites, which were used for the blade swapping w
(F) Recombinant mouse MMP3 catalytic domain (mM3-CD) cleaves soluble Wnt
double-taggedWnt5b was incubated in the presence (mM3-CD) or absence (moc
the mobility of Wnt5b by anti-HA and anti-myc western blotting before and after
the right.
(G) A structural model of Wnt5b was generated based on a recent crystal struct
overlaps with the putative coreceptor binding domain (dotted circle).
(H) Complex of MMP3 (blue) andWnt5b (green with minimal MMP3 binding doma
Experimental Procedures.
See also Table S1.
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that MMP3 promotes the expansion of MaSCs or blocks their
differentiation.
We next assessed MaSC function using fluorescence-acti-
vated cell-sorted MMP3-overexpressing MECs. Using the mam-
mosphere formation assay, we found that increased expression
of MMP3 enhanced the clonal proliferative capacity of MECs
(Figure 6B). This increase in sphere formation was reversed to
control levels by inhibition of canonical Wnt signaling using the
tankyrase inhibitor JW-55 (Figure 6C), suggesting that the effect
of MMP3 on sphere formation involves activation of canonical
Wnt signaling. In vivo reconstitution experiments revealed a sig-
nificant increase in gland-reconstituting efficiency of MECs that
overexpress MMP3 (Figures 6D, S5A, and S5B). Taken together,
these data indicate that MMP3 may promote MaSC function.
Loss of MMP3 Results in Decreased MaSC Number and
Function
We then used MMP3 null mice as a loss-of-function model to
interrogate the importance of MMP3 in the maintenance of the
MaSC pool in vivo because decreased branching morphogen-
esis was observed previously in these mice (Wiseman et al.,
2003). Indeed, MMP3 null glands displayed a loss of the basal/
MaSC population (CD24/CD49fhi) and a concomitant gain of
CD24/CD49flo mature cells (Figure 7A).
Using the mammosphere formation assay, we found that
MECs from MMP3 null mice produced 50% fewer spheres
than cells from WT mice (Figure 7B), with reduced size, and a
predominantly luminal gene expression profile by qPCR analysis
(Figure S6A). This defect in sphere formation was reversed toWT
levels by the addition of exogenous canonical Wnt3a ligand (Fig-
ure 7C) and by knocking down Wnt5b in MMP3-deficient MECs
using lentiviral shRNA (Figures 7D, S6B, and S6C), supporting
the hypothesis that MMP3 regulates MaSC through Wnt5b.
To assess MaSC function directly, we analyzed the organ-
regenerative capacity of single MECs using a limiting dilution
transplantation assay. MECs from MMP3 null and WT glands
were injected contralaterally into the epithelium-cleared inguinal
fat pads of WTmice (i.e., MMP3 sufficient) and allowed to recon-
stitute for 8 weeks. MECs from MMP3 null mice possessed a 7-
fold reduction in reconstituting efficiency compared toWTMECsd as bait in the Y2H screen.
rminal 147 amino acids (aa) of Wnt5b. All Y2H interactions were identified by
which was rated as strong (++), weak (+), or not detectable ().
nlyWnt5a andWnt5b interact withMMP3-HPX. The percent identity with the C
acids on Wnt5b (W232-Y287; pink) that is sufficient for the Y2H interaction with
ecessary for Wnt5b binding. Silent point mutations were introduced in MMP3-
ith MMP10-HPX.
5b. Serum-free culture supernatant from NIH 3T3 cells transduced to express
k) of activated mM3-CD. Each of these samples was then split in half to assess
N-glycosidase F treatment. Molecular weight (MW) markers are indicated on
ure of Wnt8. Minimal MMP3 binding domain is highlighted (pink) and strongly
in in pink) was generated by molecular docking as detailed in the Supplemental
nc.
Figure 4. Wnt5b Activates Noncanonical Wnt Signaling and Inhibits Mammary Outgrowth In Vitro and In Vivo
(A) Incubation of the MEC line Eph4 after incubation with recombinant mouse Wnt5b for 24 hr increased levels of NFAT protein as determined by western blot.
(B) A secreted alkaline phosphatase (SEAP)-based NFAT reporter assay was used in Eph4 cells. NFAT transcriptional activity was significantly increased after
incubation with recombinant mouse Wnt5b. Incubation with recombinant MMP3-FL had no effect on basal NFAT-SEAP levels but significantly inhibited NFAT
induction by Wnt5b. Data are shown as mean ± SD. *p < 0.05.
(C) Eph4 cells were transfected with a TOP-SEAP reporter to monitor canonical Wnt signaling and subsequently incubated with combinations of Wnt3a,
DKK1, and Wnt5b. Wnt3a promoted canonical Wnt signaling, which could be inhibited by DKK1 and to a lesser extent by Wnt5b. Data are shown as mean ± SD.
*p < 0.05.
(D) The MEC line NMuMG was treated with combinations of Wnt3a, DKK1, Wnt5b, and MMP3-HPX-conditioned media. Canonical Wnt signaling was monitored
bywestern blot analysis for LRP6 phosphorylation, with total LRP6 serving as a loading control. Canonical Wnt3a induced robust phosphorylation of LRP6, which
was inhibited by both DKK1 and Wnt5b. The inhibition by Wnt5b could be partially rescued with MMP3-HPX-conditioned media.
(legend continued on next page)
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quency of stem cells in MMP3 null glands was 1 out of 3,966
compared to 1 out of 763 in WT glands. This indicates that the
number of stem cells is reduced in MMP3 null mammary glands
and suggests that MMP3 is a regulator of MaSCs (Figure 7F).
DISCUSSION
Extracellular signals released from the microenvironment
strongly affect epithelial homeostasis and adult stem cell
function (Wagers, 2012). In our study, we have identified the
extracellular protease MMP3 as a factor provided by the micro-
environment that regulates Wnt signaling and adult stem cell
function in the mammary gland. Furthermore, our results offer
insights into the role of noncanonical Wnt signaling in MaSCs
and show that extracellular proteolysis is amechanism to specif-
ically control noncanonical Wnt signaling. These findings have
implications for the role of MMPs in general in regenerative
medicine and in cancer.
Wnt signaling needs to be regulated precisely because aber-
rant Wnt signaling can cause a wide range of human pathologies
including cancer (Clevers and Nusse, 2012). There are several
natural, endogenous Wnt inhibitors such as secreted Frizzled-
related proteins (sFRPs) or Wnt-inhibitory factor (WIF) that bind
directly to Wnt ligands and interfere with their receptor interac-
tion (Kawano and Kypta, 2003). Our study adds MMP3 to the
list of natural Wnt inhibitors and provides unprecedented evi-
dence for an extracellular protease as a direct regulator of Wnt
signaling.
In contrast to previously described Wnt antagonists that only
bind and sequester Wnt ligands, MMP3 inhibits ligand activity
of Wnt5b and Wnt5a both by sequestration via its HPX domain
and by proteolytic cleavage of Wnt5’s C-terminal domain. Our
structural analysis revealed that MMP3-mediated binding
and cleavage occur within the putative coreceptor domain of
Wnt5b, which explains our result that MMP3 inactivates Wnt5b-
mediated NFAT signaling. The proteolytic cleavage of Wnt5b is
irreversible; thus, one MMP3molecule may potentially inactivate
multipleWnt5bmolecules, suggesting thatMMP3maybe a high-
ly efficient Wnt antagonist. Future research needs to determine
the physiological relevance of proteolytic degradation of Wnt5b
versus inhibition by sequestration through the MMP3 HPX
domain, for example, by specifically mapping the cleavage sites
on Wnt5b and rendering this molecule resistant to MMP3 degra-
dation without altering its coreceptor binding capacity.
Our studies shed light on the role of Wnt5b as a noncanonical
Wnt ligand that modulates mammary epithelial growth and
development. We discovered that Wnt5b functions as a nonca-
nonical Wnt ligand that activates the NFAT pathway and inhibits(E) MECs (5,000 cells per well) were subjected to the mammosphere assay in the
formation, whereas addition ofMMP3 abolished the inhibitory effect ofWnt5b. Rep
presented as mean ± SEM. *p < 0.05.
(F–H) Lentiviral overexpression ofWnt5b and DKK1 inMEC transplants was used t
normal mammary epithelial structures, whereas overexpression of both Wnt5b (
growth in vivo showing abrogated outgrowths and weak fluorescence.
(I) Schematic of MMP3 as a modulator of Wnt signaling. Wnt5b activates the nonc
Wnt signaling either by competition for coreceptor Frizzled (black arrows) or dow
thereby indirectly enhances canonical Wnt signaling and downstream expressio
See also Figure S3.
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inmammary cells remains elusive, the inhibition of canonical Wnt
signaling is most likely due to competition for Frizzled corecep-
tors (Grumolato et al., 2010). Of note,Wnt5a signaling can induce
MMP3 expression in MECs (Prieve and Moon, 2003). This adds
another layer of complexity because MMP3 may act as a nega-
tive feedback factor on Wnt5-mediated noncanonical Wnt
signaling.
In themammary gland, canonical Wnt ligands are key extrinsic
signals of the stem cell niche that are mainly released by stromal
cells to promote the self-renewal capacities of MaSCs (Zeng and
Nusse, 2010). Although canonical Wnt ligands strongly promote
stem cell proliferation in the mammary gland, the role of nonca-
nonical Wnt ligands remained elusive. In accordance with previ-
ous work on Wnt5a in mammary gland development (Roarty
et al., 2009; Roarty and Serra, 2007), our data now establish
Wnt5b as a noncanonical Wnt ligand that inhibits mammary
outgrowth and branching morphogenesis, suggesting that
Wnt5 ligands may interfere with MaSC function. This notion is
supported by a recent study showing that Wnt5a blocks the pro-
liferation of intestinal epithelial stem cells (Miyoshi et al., 2012).
Increased levels ofWnt5b expression in themammary gland dur-
ing mid-to-late pregnancy suggest that this factor may control
the pregnancy-related burst of growth and proliferation of the
mammary epithelium.
The localization of MMP3 expression may be key to its stem
cell regulatory function and to its tumor-inducing role. Under
normal conditions, MMP3 is mainly expressed by stromal cells
of the microenvironment that are in direct spatial proximity to
the basal cell layer of the ductal epithelium (Kouros-Mehr and
Werb, 2006) and, to a lesser extent, by basal epithelial cells
themselves, which show an enrichment of MMP3 expression
compared to luminal cells (Kendrick et al., 2008). In contrast,
the noncanonical ligands Wnt5a and Wnt5b are predominantly
expressed in mature luminal cells (Ji et al., 2011; Kouros-Mehr
and Werb, 2006). The inactivation of luminal-derived Wnt5b by
MMP3 from basal or stromal cells may be crucial during phases
of active epithelial reorganization, such as during puberty, preg-
nancy, or regeneration, to dampen the noncanonical Wnt axis
and thereby promote canonical Wnt-driven proliferation of
MaSCs to maintain tissue homeostasis.
This stem cell-promoting function of MMP3 may be the expla-
nation for its protumorigenic properties because stem cell
expansion in response to elevated Wnt signaling can lead to
malignant conversion. The multistage neoplastic progression
induced by MMP3 (Sternlicht et al., 1999, 2000,; Witty et al.,
1995) resembles the malignant conversion that occurs in mam-
mary glands with ectopic activation of the canonical Wnt
signaling pathway by Wnt1 overexpression (Welm et al., 2008).presence of Wnt5b with or without MMP3. Wnt5b significantly inhibited sphere
resentative images are shownwith the scale bar representing 100 mm.Data are
o study their effect onmammary outgrowth in vivo. Control transplants (F) show
G; n = 10) and the Wnt inhibitor DKK1 (H; n = 6) strongly inhibited mammary
anonical NFAT signaling pathway possibly through ROR and inhibits canonical
nstream interference with b-catenin signaling. MMP3 inactivates Wnt5b and
n of Wnt-regulated genes.
nc.
(legend on next page)
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Figure 6. MMP3 Overexpression Promotes
MaSC Capacity
(A) Flow cytometry analysis revealed an altered
ratio of basal/MaSCs (CD24+/CD49fhi) versus
luminal (CD24+/CD49flo) cells in MMP3-FL-over-
expressing transplants. The basal versus luminal
cell ratio is depicted in a bar graph and was
determined from three independent experiments.
Data are represented as mean ± SEM. *p < 0.05.
(B and C) Fluorescence-activated cell-sorted len-
tivirally transduced MECs were subjected to the
mammosphere assay (5,000 cells per well). MMP3
overexpression promoted mammosphere forma-
tion compared to nontransduced control cells
andcontrol vector-transducedcells (B). Addition of
the tankyrase inhibitor JW-55 blocks MMP3-
mediated increase inmammosphere formation (C).
Data are presented as mean ± SEM. *p < 0.05.
(D) MMP3 overexpression promotes mammary
reconstitution in vivo. Fluorescence-activated
cell-sorted MECs were transplanted in two di-
lutions (100 cells and 1,000 cells) into epithelium-
cleared fat pads of recipient mice. Transplants
were harvested after 6 weeks. Reconstitution ef-
ficiencies and calculated stem cell frequencies of
MECs are listed in the table.
See also Figure S5.
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late Wnt signaling. Our findings are also relevant for human can-
cers, where MMP3 expression is frequently upregulated in the
tumor cells themselves (reviewed in Egeblad and Werb, 2002).Figure 5. MMP3 Overexpression Enhances Canonical Wnt Signaling in Mammary Transplants
(A–D) Comparison of MMP3-FL-induced mammary phenotype to overexpression of selectedWnt ligands in mammary transplants. Overexpression of MMP3-FL
(A) and canonical ligandsWnt1 (B; n = 6) andWnt2 (C; n = 5) resulted in comparable phenotype showing excess branching and epithelial growth. Overexpression
of Wnt4 (D; n = 5) caused strong enlargement of terminal end buds. Scale bars represent 1 mm.
(E–G) Paraffin sections of 10-week-old transplants from control (E), MMP3-FL (F)-, and Wnt1 (G)-overexpressing transplants were immunostained for b-catenin
(green). Confocal microscopy analysis revealed nuclear b-catenin (Cat.) by colocalizationwith DNA (blue). Percentage of cells presenting with nuclear b-catenin is
indicated for five microscopic images per sample. Scale bars represent 50 mm. Control versus MMP3-FL: p < 0.05; Control versus Wnt1: p < 0.05.
(H and I) MECs from Axin2-LacZmice were transduced with control (n = 2) andMMP3-FL (n = 2)-overexpressing lentiviruses and transplanted into the cleared fa
pads of recipient nude mice. Compared to control transplants (H), MMP3-FL overexpression (I) resulted in significantly increased X-gal staining (blue color)
Sections were counterstained with nuclear fast red, and the percentage of LacZ-positive cells per five fields of view was quantified. Scale bars represent 1 mm
Control versus MMP3-FL: p < 0.05.
See also Figure S4.
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might skew the balance between canon-
ical and noncanonical Wnt signaling in
favor for the promotion of cancer stem
cells.
Blocking MMP3 function may help to
interfere therapeutically with its protu-
morigenic role and possibly target cancer
stem cells. In previous clinical cancer tri-
als, synthetic small molecule inhibitors
designed to block MMP catalytic activity
yielded disappointing results (Coussens
et al., 2002). However, MMPs may also
act nonproteolytically (reviewed in Kes-
senbrock et al., 2010). Our data show
that MMP3 works through its HPXdomain, which is in line with recently published work from others
(Correia et al., 2013). These findings corroborate the idea that
MMPs function in a nonproteolytic manner, which would not
be inhibited by the compound inhibitors used in these clinicat
.
.
Figure 7. MECs from MMP3 Null Mice Have Reduced MaSC Capacity
(A) MaSC populations were examined in primary mammary epithelial preparations from 7-week-old MMP3-sufficient and deficient mice as Lin-negative CD24-
positive and CD49f-high cells by flow cytometry analysis. The ratio of basal/MaSCs (CD24+/CD49fhi; blue) versus luminal (CD24+/CD49flo; green) cells was
significantly decreased in MMP3 null mice. Data are represented as mean ± SEM (n = 4). *p < 0.05.
(B) MECs from MMP3 null mice have a reduced ability to form mammospheres. Representative DIC images are shown; scale bars represent 100 mm. Bar graph
depicts the average number of spheres per well seeded with 1,000 MECs; results from three independent experiments are shown. Data are shown as mean ±
SEM. *p < 0.05.
(C and D) MECs from WT and MMP3 null mice (5,000 cells per well) were subjected to the mammosphere assay. Addition of Wnt3a (100 ng/ml) to MMP3 null
MECs increased sphere-forming potential to the level of WT MECs (C). Similarly, knockdown of Wnt5b (SH1 and SH2; 1,000 cells per well) significantly rescued
mammosphere formation of MMP3 null MECs compared to Scramble control (D). Data are pooled from two independent experiments. *p < 0.05.
(E) Mammary gland-reconstituting activity of WT and MMP3 null MECs was determined by limiting dilution transplants (10,000/1,000/100 cells). The cutoff for
positive reconstitution was 20% of mammary fat pad filling. Reconstitution efficiencies and calculated stem cell frequencies of MECs from WT and MMP3/
mice are listed in the table. Data are pooled from two independent experiments.
(F) Model of MMP3 as a stroma and basal cell-derived modulator of epithelial homeostasis in the mammary gland. Basal stem cells are stimulated by canonical
Wnt ligands such asWnt1 orWnt2.Wnt5b functions as an inhibitor of canonicalWnt signaling and interferes withmammary epithelial outgrowth. MMP3 produced
in the vicinity of mammary epithelial ducts binds and inactivates Wnt5b, leading to increased canonical Wnt signaling and expansion of basal/stem-like epithelial
cells.
See also Figure S6.
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tions of MMPs could be a more effective treatment strategy for
patients with cancer. Indeed, small molecule inhibitors targeting
the HPX domain of MMP14 have been successfully used to
reduce mammary tumor growth in mice (Remacle et al., 2012).
Further research should focus on identifying inhibitors of the
nonproteolytic functions of MMP3 and other MMPs.
In conclusion, our study unravels a molecular mechanism for
the regulation of Wnt signaling through the extracellular protein-
ase MMP3, which specifically binds and inactivates the nonca-
nonical ligand Wnt5b. We shed light on the role of Wnt5b as a
negative regulator of MaSCs. Therefore, MMP3 is part of a reg-
ulatory network that orchestratesWnt signaling and adult epithe-
lial stem cell function (Figure 7F). This may affect the function ofCell Scancer stem cells during tumor initiation and metastasis in dis-
eases such as breast cancer. The observation that MMP3 can
act in a nonproteolytic manner via its HPX domain may pave
the way for the development of novel therapeutic approaches
to treat breast cancer by interfering with their noncatalytic bio-
logical properties.
EXPERIMENTAL PROCEDURES
Mice
FVB/N mice were purchased from Charles River Laboratories (Wilmington).
MMTV-Wnt1 mice (Tsukamoto et al., 1988), MMP3/stromelysin-1 null mice
(Mudgett et al., 1998), and Axin2-LacZ mice (Lustig et al., 2002) have been
described previously. All mouse strains were backcrossed to the FVB/N back-
ground. Experiments with mutant mice used littermates as controls. Mice weretem Cell 13, 300–313, September 5, 2013 ª2013 Elsevier Inc. 311
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MMP3 Regulates MaSCs through Wnt Signalingmaintained in a pathogen-free facility. All mouse procedures were approved
by the University of California, San Francisco, Institutional Animal Care and
Use Committee.
Preparation of Primary Mouse MECs, Viral Transduction,
Transplantation, and Analysis of Reconstituted Mammary Glands
Primary MECs were isolated from inguinal mammary glands (#4) of 8- to 12-
week-old donor mice, were prepared by differential centrifugation, transduced
with lentivirus overnight in ultralow adhesion plates, and transplanted into
cleared fat pads of recipient mice, and the reconstituted mammary glands
were analyzed as previously described by Welm et al. (2008). Details are pro-
vided in the Supplemental Experimental Procedures.
Mammosphere Assay
Mammosphere assays were carried out as described previously by Shackle-
ton et al. (2006) and Stingl et al. (2006). Details are given in the Supplemental
Experimental Procedures.
Measuring Mammary-Reconstituting Activity
Limiting dilutions ofMECswere transplanted into cleared contralateral inguinal
mammary glands of syngeneic recipient mice. Positive reconstitution was
determined at 6–8 weeks after transplantation using carmine red staining of
mammary whole mounts. The MaSC frequency was calculated according to
Hu and Smyth (2009).
Y2H Screen
Y2H studies were performed as previously described by Li et al. (2002) and are
detailed in the Supplemental Experimental Procedures.
Cell Culture Analysis of Wnt Signaling
The nontumorigenic mouse mammary cell lines NMuMG or Eph4 were used to
study canonical Wnt by western blot and using Wnt reporter assays that were
performed essentially as described previously (Shahi et al., 2012) as detailed in
the Supplemental Experimental Procedures.
Structural Modeling of Wnt5b and MMP3
Comparative protein structure modeling for Wnt5b andMMP3 was carried out
using the automated comparative protein structure-modeling pipeline MOD-
PIPE and is detailed in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2013.06.005.
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